Condensate News: “Redefining druggable targets with artificial intelligence”

AI + new modalities are rewriting what counts as “druggable.” A Nat Biotech Comment — the synthesis of a Cancer Moonshot Workshop, shows how condensates are moving from mystery to target class — where biomarkers, benchmarks & AI-driven modulators will drive the next wave of therapeutic discovery, and maps a paradigm shift: from active sites to condensates, degraders & polypharmacology — where AI is expanding the druggable universe. Read the full comment at the link below below:

Redefining druggable targets with artificial intelligence